Tag: Clinical Trials

Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is ‘safe’ or effective, only that the trial may be conducted.

Clinical trials of drugs for autoimmune diseases and cancer soon to start in Russia

Clinical trials of about 30 new medicinal products for the treatment of cancer, autoimmune and hereditary diseases are expected to start in the Russian Federation

Petrovax presented the results of clinical trials for quadrivalent vaccine

NPO Petrovax Pharm presented the results of clinical trials for the first Russian-made quadrivalent vaccine

Recipharm and CTC started up a clinical trials management service

Swedish contract development and manufacturing organisation Recipharm and contract research organisation Clinical Trial Consultants have partnered to launch a new service

Merck KGaA will lead Global Oncology Big Data Alliance

merck kgaa
Merck KGaA has announced that it will enter into a strategic collaboration with Project Data Sphere LLC to jointly lead the Global Oncology Big Data Alliance

BIOСAD completes clinical trials of a biosimilar for anemia treatment

BIOСAD has completed the program of clinical trials for the first Russian-made darbepoetin alfa for the treatment of anemia in patients with chronic renal failure and oncological diseases

A new drug assessment method developed in Russia

Russian scientists proposed a new method for assessing the medicines that will allow to avoid testing drugs in humans

Jazz Pharmaceuticals and ImmunoGen teamed up to develop ADC programs

Jazz Pharmaceuticals and ImmunoGen, Inc. entered into a collaboration and option agreement

ARMO BioSciences received $67 million budgeting for immunotherapy studies

ARMO BioSciences, Inc., a late-stage immuno-oncology company, today announced the successful completion of a $67 million private financing led by new investor Qiming Venture Partners

Dutch CRO Viroclinics Biosciences was bought by Parcom Capital

Parcom Capital, a leading mid-market private equity fund, has acquired the successful clinical research organisation Viroclinics Biosciences

National Cancer Center of Japan sets up a new drug development system

Japan's National Cancer Center will establish a system for cooperating on the development of cancer drugs with four medical institutions in South Korea, Taiwan, Singapore and Hong Kong

Novartis tests the new compound against drug-resistant malaria

Novartis and Medicines for Malaria Venture have launched a patient trial for KAF156

Novo Nordisk’s diabetes drug reached a goal in key stage of clinical trial

Novo Nordisk
Novo Nordisk, a Danish multinational pharmaceutical company, yesterday announced the positive trial results of its diabetes drug.

Sihuan Pharmaceutical launched R&D centre in California

Sihuan Pharmaceutical announced that the Group has recently set up its Research and Development Centre in the San Francisco Bay Area

Regeneron stopped development of antibody to RSV

Regeneron Pharmaceuticals announced that a Phase 3 study evaluating suptavumab, an antibody to respiratory syncytial virus, did not meet its primary endpoint

PCI Clinical Services will start a new service for clinical trials

clinical trial
PCI Clinical Services has announced the launch of expedited Clinical packaging, labeling and distribution service FastTrack

PRA Health Sciences aquired Symphony Health Solutions Corporation

clinical trials
PRA Health Sciences, Inc., a leading clinical research organization, announced it has signed a definitive agreement to acquire Symphony Health Solutions Corporation